/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/
Avicanna Inc. (” Avicanna ” or the ” Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announces the filing of the Company’s audited annual financial statements for the year ended December 31, 2020, and accompanying management’s discussion and analysis, annual information form and related certifications (collectively, the “ Documents ”). Electronic copies of the Documents are available on SEDAR (www.sedar.com) under the Company’s issuer profile.
The Company is in the process of preparing its unaudited interim financial statements, management’s discussion and analysis, and related certifications (collectively, the “ Interim Filings ”) for each of the three month periods ended March 31, 2021 and June, 30, 2021, respectively, and anticipates filing the Interim Filings on or prior to September 9, 2021.
Upon the filing of the Interim Filings, the Issuer anticipates that its continuous disclosure record will be up to date in accordance with applicable securities law and intends to seek the revocation of the cease trade order issued by the Ontario Securities Commission in respect of the Company on June 11, 2021.
Stay Connected
For more...
Read Full Story: https://investingnews.com/daily/cannabis-investing/avicanna-announces-filing-of-annual-financial-statements-for-year-ended-december-31-2020/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.